Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease

Ahn, 2020, Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19), J. Microbiol. Biotechnol., 30, 313, 10.4014/jmb.2003.03011 Anusuya, 2017, Quercetin derivatives as non-nucleoside inhibitors for dengue polymerase: molecular docking, molecular dynamics simulation, and binding free energy calculation, J. Biomol. Struct. Dyn., 35, 2895, 10.1080/07391102.2016.1234416 Aref, 2006, Cyclin D1 expression in acute leukemia, Hematology, 11, 31, 10.1080/10245330500322321 Báez-Santos, 2015, The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds, Antiviral Res., 115, 21, 10.1016/j.antiviral.2014.12.015 Barretto, 2005, The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity, J. Virol., 79, 15189, 10.1128/JVI.79.24.15189-15198.2005 Bhakat, 2014, An integrated molecular dynamics, principal component analysis and residue interaction network approach reveals the impact of M184V mutation on HIV reverse transcriptase resistance to lamivudine, Mol. Biosyst., 10, 2215, 10.1039/C4MB00253A Caly, 2020, The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro, Antiviral Res., 104787, 10.1016/j.antiviral.2020.104787 Case, 2018 Chen, 2009, Thiopurine analogue inhibitors of severe acute respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzyme, Antivir. Chem. Chemother., 19, 151, 10.1177/095632020901900402 Chen, 2016, Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein–protein binding free energies and re-rank binding poses generated by protein–protein docking, J. Chem. Soc. Faraday Trans., 18, 22129 Cheng, 2015, Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus, Antiviral Res., 115, 9, 10.1016/j.antiviral.2014.12.011 Chou, 2008, Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus, Biochem. Pharmacol., 75, 1601, 10.1016/j.bcp.2008.01.005 Chou, 2014, Structural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like protease, Acta Crystallogr. D Biol. Crystallogr., 70, 572, 10.1107/S1399004713031040 Chuang, 2018, 6-Thioguanine is a noncompetitive and slow binding inhibitor of human deubiquitinating protease USP2, Sci. Rep., 8, 1, 10.1038/s41598-018-21476-w Davis, 2016, Small molecule inhibition of the ubiquitin-specific protease USP2 accelerates cyclin D1 degradation and leads to cell cycle arrest in colorectal cancer and mantle cell lymphoma models, J. Biol. Chem., 291, 24628, 10.1074/jbc.M116.738567 Du, 2012, Recent progress in structure-based anti-influenza drug design, Drug Discov. Today, 17, 1111, 10.1016/j.drudis.2012.06.002 Feldmann, 2011, Ebola haemorrhagic fever, Lancet, 377, 849, 10.1016/S0140-6736(10)60667-8 Fernandes, 2018, Increased levels of cyclin D1 negatively impacts on acute lymphoblastic leukemia overall survival, Appl. Cancer Res., 38, 7, 10.1186/s41241-018-0058-8 Ghosh, 2010, Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein− ligand X-ray structure and biological evaluation, J. Med. Chem., 53, 4968, 10.1021/jm1004489 Greenidge, 2014, Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA, J. Chem. Inf. Model., 54, 2697, 10.1021/ci5003735 Guan, 2017, Exploration of binding and inhibition mechanism of a small molecule inhibitor of influenza virus H1N1 hemagglutinin by molecular dynamics simulation, Sci. Rep., 7, 10.1038/s41598-017-03719-4 Halford, 2012, From discovery to drug, Chem. Eng. News, 90, 34, 10.1021/cen-09035-scitech1 Hilgenfeld, 2014, From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design, FEBS J., 281, 4085, 10.1111/febs.12936 Hou, 2007, Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance, J. Med. Chem., 50, 1177, 10.1021/jm0609162 Hou, 2011, Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations, J. Chem. Inf. Model., 51, 69, 10.1021/ci100275a Hou, 2011, Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations, J. Chem. Inf. Model., 51, 69, 10.1021/ci100275a Hu, 2002, Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde, Cell, 111, 1041, 10.1016/S0092-8674(02)01199-6 Hu, 2005, Structure and mechanisms of the proteasome‐associated deubiquitinating enzyme USP14, EMBO J., 24, 3747, 10.1038/sj.emboj.7600832 Ikram, 2019, Inhibition of oncogenic kinases: an in vitro validated computational approach identified potential multi-target anticancer compounds, Biomolecules, 9, 10.3390/biom9040124 Kiss, 2012, http://Mcule. com: a public web service for drug discovery, J. Cheminform., 4, P17, 10.1186/1758-2946-4-S1-P17 Leela, 2016, Drug repurposing of minocycline against dengue virus infection, Biochem. Biophys. Res. Commun., 478, 410, 10.1016/j.bbrc.2016.07.029 Lei, 2014, Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features, Antiviral Res., 109, 72, 10.1016/j.antiviral.2014.06.011 Lindner, 2005, The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme, J. Virol., 79, 15199, 10.1128/JVI.79.24.15199-15208.2005 Liu, 2020 Luzhkov, 2013, Evaluation of adamantane derivatives as inhibitors of dengue virus mRNA cap methyltransferase by docking and molecular dynamics simulations, Mol. Inform., 32, 155, 10.1002/minf.201200107 Madrid, 2013, A systematic screen of FDA-approved drugs for inhibitors of biological threat agents, PLoS One, 8, e60579, 10.1371/journal.pone.0060579 Mielech, 2014, Nidovirus papain-like proteases: multifunctional enzymes with protease, deubiquitinating and deISGylating activities, Virus Res., 194, 184, 10.1016/j.virusres.2014.01.025 Mirza, 2016, Integrated computational approach for virtual hit identification against ebola viral proteins VP35 and VP40, Int. J. Mol. Sci., 17, 10.3390/ijms17111748 Mirza, 2016, Towards peptide vaccines against Zika virus: immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins, Sci. Rep., 6, 37313, 10.1038/srep37313 Mirza, 2019, In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential crimean-congo hemorrhagic fever virus inhibitors, Sci. Rep., 9, 1, 10.1038/s41598-019-43129-2 Mottin, 2017, Molecular dynamics simulations of Zika virus NS3 helicase: insights into RNA binding site activity, Biochem. Biophys. Res. Commun., 10.1016/j.bbrc.2017.03.070 Nitsche, 2018, Strategies towards protease inhibitors for emerging flaviviruses, 175 Osipiuk, 2020, Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors, bioRxiv Papa, 2008, Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells, Leukemia, 22, 147, 10.1038/sj.leu.2404980 Parida, 2014, Potential of plant alkaloids as dengue ns3 protease inhibitors: molecular docking and simulation approach, Bangladesh J. Pharmacol., 9, 262 Pattnaik, 2018, Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening, Antiviral Res., 151, 78, 10.1016/j.antiviral.2017.12.016 Pieters, 1992, Hypoxanthine‐guanine phosphoribosyl‐transferase in childhood leukemia: relation with immunophenotype, in vitro drug resistance and clinical prognosis, Int. J. Cancer, 51, 213, 10.1002/ijc.2910510208 Qu, 2015, USP2 promotes cell migration and invasion in triple negative breast cancer cell lines, Tumor Biol., 36, 5415, 10.1007/s13277-015-3207-7 Quesada, 2004, Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases, Biochem. Biophys. Res. Commun., 314, 54, 10.1016/j.bbrc.2003.12.050 Ramajayam, 2010, Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease, Bioorg. Med. Chem. Lett., 20, 3569, 10.1016/j.bmcl.2010.04.118 Rastelli, 2010, Fast and accurate predictions of binding free energies using MM‐PBSA and MM‐GBSA, J. Comput. Chem., 31, 797 Ratia, 2006, Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme, Proc. Natl. Acad. Sci., 103, 5717, 10.1073/pnas.0510851103 Ratia, 2008, A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication, Proc. Natl. Acad. Sci., 105, 16119, 10.1073/pnas.0805240105 Renatus, 2006, Structural basis of ubiquitin recognition by the deubiquitinating protease USP2, Structure, 14, 1293, 10.1016/j.str.2006.06.012 Rosenbaum, 2020, Facing Covid-19 in Italy—ethics, logistics, and therapeutics on the epidemic’s front line, N. Engl. J. Med., 382, 1873, 10.1056/NEJMp2005492 Sanders, 2020, Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review, Jama, 323, 1824 Seley-Radtke, 2018, The evolution of nucleoside analogue antivirals: a review for chemists and non-chemists. Part 1: early structural modifications to the nucleoside scaffold, Antiviral Res., 154, 66, 10.1016/j.antiviral.2018.04.004 Shan, 2009, Suppression of cancer cell growth by promoting cyclin D1 degradation, Mol. Cell, 36, 469, 10.1016/j.molcel.2009.10.018 Shin, 2020, Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity, Nature, 1 Shurtleff, 2012, Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design, Expert Opin. Drug Discov., 7, 935, 10.1517/17460441.2012.714364 Sirin, 2014, A computational approach to enzyme design: predicting ω-aminotransferase catalytic activity using docking and MM-GBSA scoring, J. Chem. Inf. Model., 54, 2334, 10.1021/ci5002185 Speelman, 2001, Molecular dynamics simulations of human rhinovirus and an antiviral compound, Biophys. J., 80, 121, 10.1016/S0006-3495(01)75999-1 Srivastava, 2012, Molecular dynamics investigation on a series of HIV protease inhibitors: assessing the performance of MM-PBSA and MM-GBSA approaches, J. Chem. Inf. Model., 52, 3088, 10.1021/ci300385h Su, 2018, Comparative assessment of scoring functions: the CASF-2016 update, J. Chem. Inf. Model., 59, 895, 10.1021/acs.jcim.8b00545 Sulea, 2005, Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain-like protease?, J. Virol., 79, 4550, 10.1128/JVI.79.7.4550-4551.2005 Sulea, 2006, Binding site‐based classification of coronaviral papain‐like proteases, Proteins Struct. Funct. Bioinform., 62, 760, 10.1002/prot.20802 Sun, 2018, Assessing the performance of MM/PBSA and MM/GBSA methods. 7. Entropy effects on the performance of end-point binding free energy calculation approaches, J. Chem. Soc. Faraday Trans., 20, 14450 Tahir ul Qamar, 2016, Discovery of novel dengue NS2B/NS3 protease inhibitors using pharmacophore modeling and molecular docking based virtual screening of the zinc database, Int. J. Pharmacol, 12, 621, 10.3923/ijp.2016.621.632 Tahir ul Qamar, 2020, Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants, J. Pharm. Anal., 10.1016/j.jpha.2020.03.009 Thomasy, 2016, A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1, Vet. Ophthalmol., 19, 119, 10.1111/vop.12375 Thompson, 2008, Investigation of MM-PBSA rescoring of docking poses, J. Chem. Inf. Model., 48, 1081, 10.1021/ci700470c Tu, 2017, Exploring the binding mechanism of Heteroaryldihydropyrimidines and Hepatitis B Virus capsid combined 3D-QSAR and molecular dynamics, Antiviral Res., 137, 151, 10.1016/j.antiviral.2016.11.026 Turlington, 2013, Discovery of N-(benzo [1, 2, 3] triazol-1-yl)-N-(benzyl) acetamido) phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding, Bioorg. Med. Chem. Lett., 23, 6172, 10.1016/j.bmcl.2013.08.112 Wang, 2009, A small-molecule dengue virus entry inhibitor, Antimicrob. Agents Chemother., 53, 1823, 10.1128/AAC.01148-08 Wang, 2017, Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study, Eur. J. Med. Chem., 137, 450, 10.1016/j.ejmech.2017.05.045 Wang, 2020, A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence, Int. J. Antimicrob. Agents, 105948, 10.1016/j.ijantimicag.2020.105948 Wang, 2020, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res., 1 Wu, 2020, Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods, Acta Pharm. Sin. B, 10.1016/j.apsb.2020.02.008 Yamamoto, 2020, Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro, bioRxiv Young, 2019, The role of ubiquitin-specific peptidases in cancer progression, J. Biomed. Sci., 26, 42, 10.1186/s12929-019-0522-0 Zhang, 2014 Zhang, 2017, Structure of the NS5 methyltransferase from Zika virus and implications in inhibitor design, Biochem. Biophys. Res. Commun., 492, 624, 10.1016/j.bbrc.2016.11.098 Zhou, 2008, Antiviral compounds discovered by virtual screening of small− molecule libraries against dengue virus e protein, ACS Chem. Biol., 3, 765, 10.1021/cb800176t